ALMURADOVA D.M.; RAVSHANOVA N.B.; ABDURAKHIMOV A.I. Clinical Outcomes of EGFR-Targeted Therapy with Erlotinib Versus Polychemotherapy in NSCLC: A Statistical Analysis. International Journal of Medical Sciences And Clinical Research, [S. l.], v. 6, n. 03, p. 82–86, 2026. DOI: 10.37547/ijmscr/Volume06Issue03-18. Disponível em: https://theusajournals.com/index.php/ijmscr/article/view/9783. Acesso em: 27 jul. 2026.